rs17121819

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_004588.5(SCN2B):​c.82C>T​(p.Arg28Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000458 in 1,614,176 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R28Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000042 ( 1 hom. )

Consequence

SCN2B
NM_004588.5 missense

Scores

1
5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:1

Conservation

PhyloP100: 0.854

Publications

10 publications found
Variant links:
Genes affected
SCN2B (HGNC:10589): (sodium voltage-gated channel beta subunit 2) The protein encoded by this gene is the beta 2 subunit of the type II voltage-gated sodium channel. The encoded protein is involved in cell-cell adhesion and cell migration. Defects in this gene can be a cause of Brugada Syndrome, atrial fibrillation, or sudden infant death syndrome. [provided by RefSeq, Jul 2015]
SCN2B Gene-Disease associations (from GenCC):
  • atrial fibrillation, familial, 14
    Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Genomics England PanelApp
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13055259).
BP6
Variant 11-118168740-G-A is Benign according to our data. Variant chr11-118168740-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 60769.
BS2
High AC in GnomAd4 at 12 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN2BNM_004588.5 linkc.82C>T p.Arg28Trp missense_variant Exon 2 of 4 ENST00000278947.6 NP_004579.1 O60939Q5U0K8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN2BENST00000278947.6 linkc.82C>T p.Arg28Trp missense_variant Exon 2 of 4 1 NM_004588.5 ENSP00000278947.5 O60939
SCN2BENST00000658882.1 linkn.186C>T non_coding_transcript_exon_variant Exon 3 of 5 ENSP00000499572.1 A0A590UJS3
SCN2BENST00000665446.1 linkn.318C>T non_coding_transcript_exon_variant Exon 3 of 4
SCN2BENST00000669850.1 linkn.324C>T non_coding_transcript_exon_variant Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152206
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000915
AC:
23
AN:
251286
AF XY:
0.0000957
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000424
AC:
62
AN:
1461852
Hom.:
1
Cov.:
32
AF XY:
0.0000440
AC XY:
32
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000157
AC:
7
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5746
European-Non Finnish (NFE)
AF:
0.0000387
AC:
43
AN:
1112002
Other (OTH)
AF:
0.0000828
AC:
5
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152324
Hom.:
0
Cov.:
32
AF XY:
0.0000940
AC XY:
7
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41578
American (AMR)
AF:
0.000131
AC:
2
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68014
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000138
Hom.:
0
Bravo
AF:
0.0000831
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000659
AC:
8
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Atrial fibrillation, familial, 14 Pathogenic:1Uncertain:2
Jun 01, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Nov 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 28 of the SCN2B protein (p.Arg28Trp). This variant is present in population databases (rs17121819, gnomAD 0.02%). This missense change has been observed in individual(s) with atrial fibrillation (PMID: 19808477). ClinVar contains an entry for this variant (Variation ID: 60769). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The tryptophan amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects SCN2B function (PMID: 19808477). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Jul 24, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in a patient with paroxsymal atrial fibrillation, right precordial saddleback type ST-segment elevation on ECG, and a history of hypertension in published literature (PMID: 19808477); Identified in a patient with Long QT syndrome (LQTS) who also harbored a variant in KCNH2 (PMID: 39596046); Published functional studies showed reduced peak sodium current amplitude and a positive shift in the voltage dependence of activation, but no effect on the voltage dependence of inactivation or the persistence of the sodium current compared to wild-type SCN2B (PMID: 19808477); In silico analysis suggests that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868); This variant is associated with the following publications: (PMID: 26986070, 34426522, 19808477, 35385795, 39596046) -

Cardiovascular phenotype Benign:1
Nov 21, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Uncertain
0.079
D
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.087
N
LIST_S2
Benign
0.68
T
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.13
T
MetaSVM
Uncertain
0.077
D
MutationAssessor
Benign
0.34
N
PhyloP100
0.85
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.080
N
REVEL
Uncertain
0.56
Sift
Benign
0.042
D
Sift4G
Benign
0.098
T
Polyphen
0.83
P
Vest4
0.21
MVP
0.98
MPC
0.25
ClinPred
0.069
T
GERP RS
2.7
Varity_R
0.41
gMVP
0.52
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17121819; hg19: chr11-118039455; API